0 works0 citations0 h-indexGoogle ScholarOpenAlexChangai YueResearch AreasChronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Click Chemistry and ApplicationsMost-Cited Works→ Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials(2020)26 cited